CONTI, Pio
 Distribuzione geografica
Continente #
NA - Nord America 9.927
AS - Asia 6.110
EU - Europa 5.978
SA - Sud America 649
Continente sconosciuto - Info sul continente non disponibili 545
AF - Africa 86
OC - Oceania 7
Totale 23.302
Nazione #
US - Stati Uniti d'America 9.695
SG - Singapore 2.308
CN - Cina 1.763
UA - Ucraina 1.055
IE - Irlanda 834
GB - Regno Unito 796
TR - Turchia 782
SE - Svezia 697
RU - Federazione Russa 628
IT - Italia 579
BR - Brasile 530
VN - Vietnam 488
DE - Germania 483
FR - Francia 467
IN - India 383
FI - Finlandia 224
CA - Canada 136
HK - Hong Kong 84
BD - Bangladesh 64
AR - Argentina 57
MX - Messico 50
PL - Polonia 43
ES - Italia 37
KR - Corea 37
JP - Giappone 34
ZA - Sudafrica 34
BE - Belgio 31
CZ - Repubblica Ceca 31
IQ - Iraq 25
IL - Israele 17
IR - Iran 17
EC - Ecuador 16
NL - Olanda 15
CO - Colombia 14
EU - Europa 14
ID - Indonesia 14
JM - Giamaica 14
CL - Cile 12
UZ - Uzbekistan 12
KE - Kenya 11
LT - Lituania 11
SA - Arabia Saudita 11
PK - Pakistan 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
RO - Romania 9
HN - Honduras 8
TN - Tunisia 8
AT - Austria 7
EG - Egitto 7
MY - Malesia 7
PH - Filippine 7
CR - Costa Rica 6
TT - Trinidad e Tobago 6
AU - Australia 5
DZ - Algeria 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
GR - Grecia 4
JO - Giordania 4
MA - Marocco 4
MD - Moldavia 4
OM - Oman 4
ET - Etiopia 3
HR - Croazia 3
KZ - Kazakistan 3
ML - Mali 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EE - Estonia 2
GY - Guiana 2
IM - Isola di Man 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
DK - Danimarca 1
DM - Dominica 1
Totale 22.756
Città #
Singapore 1.690
San Jose 1.150
Chandler 1.131
Jacksonville 1.113
Dublin 824
Ashburn 550
Southend 531
Dallas 428
Beijing 403
Council Bluffs 400
Princeton 392
Izmir 373
Nanjing 322
Dearborn 227
Wilmington 223
Los Angeles 216
Santa Clara 207
Cambridge 187
Ho Chi Minh City 176
Ann Arbor 168
The Dalles 155
Altamura 151
Tongling 130
Boardman 124
New York 122
Buffalo 118
Nanchang 112
Hanoi 108
Munich 106
Woodbridge 98
Grevenbroich 73
Shenyang 73
Hong Kong 71
Moscow 71
Chieti 70
Houston 69
São Paulo 64
Hebei 59
Tianjin 53
Jiaxing 46
Washington 46
Columbus 45
Phoenix 45
Jinan 42
Kunming 40
Chicago 37
Denver 37
Montréal 37
Orem 36
Chennai 35
Seoul 33
Atlanta 32
Brooklyn 32
Redondo Beach 32
Augusta 30
Montreal 30
Tokyo 30
Warsaw 30
Pescara 29
Da Nang 28
Hangzhou 28
Brussels 27
Johannesburg 27
Brno 26
Helsinki 26
Norwalk 26
Boston 25
Orange 25
San Mateo 24
Turku 24
Mcallen 23
Toronto 23
Mexico City 22
Ningbo 22
Zhengzhou 22
Hefei 21
Milan 21
Rome 21
Haiphong 20
London 20
Changsha 19
Seattle 19
Auburn Hills 17
Manchester 17
Poplar 17
Stockholm 17
Dong Ket 16
Frankfurt am Main 16
Belo Horizonte 15
San Francisco 15
Brasília 14
Düsseldorf 14
Guangzhou 14
Hyderabad 14
Rio de Janeiro 14
St Louis 13
Taizhou 13
Mumbai 12
Pune 12
Bangalore 11
Totale 14.062
Nome #
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 258
Vascular endothelial growth factor (VEGF), mast cells and inflammation 191
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 189
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 184
Anti-chemochine therapy for inflammatory diseases 183
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 183
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 182
Interleukin-6 and mast cells 182
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study 181
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 181
Allergen immunotherapy: an effective immune-modifier. 177
Caffeine, Theophylline and bamifylline are similar as competitive inhibitors of 3' ,5'-cyclic AMP phosphodiesterase in vitro 171
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 171
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 167
Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line 166
A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application 164
A scavenger role for nitric oxide in the aged rat kidney. 163
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 163
Heme Oxigenase-1 (HO-1) and oxidative stress in rat heart 163
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 163
Bamifylline similar to theophylline and caffeine is a competitive inhibitor of the cyclic nucleotide phosphodiesterase V 162
Activation and inhibition of adaptive immune response mediated by mast cells 160
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 159
Nutrition and cancer prevention. 159
Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines 156
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism 154
Microarray expression profiling of human dental pulp from single subject. 153
ENOX2 (or tNOX): a new and old molecule with cancer activity involved in tumor prevention and therapy 152
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 151
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 151
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. 151
Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 148
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. 148
Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury 148
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 147
In vitro effects of vanadate on human immune functions 146
Impact of RANTES, MCP-1 and IL-8 in mast cells 144
Endocrinology of the skin: intradermal neuroimmune network, a new frontier 144
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 144
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 143
Interleukin-9 and mast cells 141
Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study 141
ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY 139
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 139
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 139
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 139
Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. 138
Calcium ionophore A23187 and compound 48/80 induce PGD2 and tryptase in human cord blood-derived mast cells: lack of effect of il-18 138
IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation 138
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines 138
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 137
Chemokines as markers for parasite-induced inflammation and tumors 137
IL-10, an inflammatory/inhibitory cytokine, but not always. 137
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 137
A new diagnostic approach to better identify antiphospholipid syndrome. 136
Interleukin-17 and the interleukin-17 family member network. 134
Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells. 134
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 134
Tridimensional response of human dental follicular stem cells onto a synthetic hydroxyapatite scaffold. 133
Relevance of plant lectins in human cell biology and immunology 133
Endothelial Nitric Oxide Synthase (e-NOS)expression and localization in healthy and diabetic rat hearts 132
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 132
Production of cytokines in trichinellosis infected mice 131
Effect of the compound L-mimosine in an in vivo model of chronic granuloma formation induced by potassium permanganate (KMNO4). 131
Morphostructural analysis of human follicular stem cells on highly porous bone hydroxyapatite scaffold. 131
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 130
Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. 130
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 130
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 128
Cytokines and allergic disorders: a revisited study 128
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 127
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 127
IL-36 a new member of the IL-1 family cytokines 127
Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue 127
IL-32: a newly-discovered proinflammatory cytokine 127
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 126
Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. 126
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 125
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 125
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 124
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 124
Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells 124
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 123
Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine. 123
Advances in therapy with antileukotriene drugs. 123
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 122
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 122
Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee 122
Interleukin-17: a revisited study. 122
Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? 121
Aluminum impairs rat neural cell mitochondria in vitro 121
Infections and mast cells 121
Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4 121
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 120
Endothelial cells, cholesterol, cytokines, and aging 120
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 119
NEUROLOGIC SOFT SIGNS IN SCHIZOPHRENIC PATIENTS TREATED WITH CONVENTIONAL AND ATYPICAL ANTIPSYCHOTICS 119
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 118
IL-1beta induces alkaline phosphatase in human phagocytes 117
Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. 116
Totale 14.326
Categoria #
all - tutte 91.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022748 0 0 4 166 64 3 16 64 54 26 104 247
2022/20232.982 258 380 181 360 328 587 162 194 373 34 62 63
2023/20241.135 95 40 66 38 63 314 313 37 19 21 13 116
2024/20253.225 234 596 579 59 69 89 47 148 281 139 364 620
2025/20266.440 539 312 752 736 568 469 1.052 445 638 501 352 76
2026/2027878 116 557 205 0 0 0 0 0 0 0 0 0
Totale 23.302